Tianjin Zhong Xin Pharmaceutical Group Corporation Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Zhong Xin Pharmaceutical Group Corporation Limited with three other
companies in this sector in China:
JiangSu Bicon Pharmaceutical Listed Co
sales of 5.37 billion Chinese Renmimbi [US$855.60 million]
of which 46%
was Pharmaceutical Intermediates),
China Medical System Holdings Limited
(5.35 billion Chinese Renmimbi [US$852.55 million]
of which 100%
was Pharmaceutical Products), and
KPC Pharmaceuticals Inc
(5.85 billion Chinese Renmimbi [US$932.80 million]
of which 43%
was Drugs Wholesale and Retail).
During the year ended December of 2017, sales at
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited were 5.69 billion Chinese Renmimbi (US$906.81 million).
decrease of 7.9%
versus 2016, when the company's sales were 6.18 billion Chinese Renmimbi.